Christopher M. Murphy - 11 Aug 2025 Form 4 Insider Report for Third Harmonic Bio, Inc. (THRD)

Role: Chief Financial & Bus. Officer
Issuer symbol: THRD
Report date: 11 Aug 2025
Net transaction value: $0
Form type: 4
Accepted by SEC: 14 Aug 2025, 16:07:34 UTC
Previous filing: 05 Mar 2025
Next filing: 13 May 2026
SEC filing: View on sec.gov
Reporting owner signature: /s/ Christopher Murphy

Key filing fact

Christopher M. Murphy filed Form 4 for Third Harmonic Bio, Inc. (THRD) on 14 Aug 2025.

Key facts

This page summarizes Christopher M. Murphy's Form 4 filing for Third Harmonic Bio, Inc. (THRD).
1 reported transaction and 1 derivative row are listed below.
Accepted by SEC: 14 Aug 2025, 16:07.

Change

Previous filing in this sequence was filed on 05 Mar 2025.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

See Original Filing

Reporting Owners (1)

CIK 0002005986 Primary reporting owner

Murphy Christopher M.

Relationship: Chief Financial & Bus. Officer
Address: C/O THIRD HARMONIC BIO, INC., 1700 MONTGOMERY STREET, SUITE 210, SAN FRANCISCO
Signature: /s/ Christopher Murphy
Signature date: 14 Aug 2025

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

THRD transaction Derivative

Restricted Stock Unit

Other

Transaction value: $0
Shares: -47,500
Change %: -100%
Price: $0.000000
Shares after: 0
Date: 11 Aug 2025
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 47,500
Exercise price
Footnotes: F1, F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

The restricted stock units were deemed vested and settled on the date of the liquidation distribution, and such settled shares received a liquidation distribution of $5.35 per share.

Footnote F2

Transaction reported is a cancellation of shares of common stock in connection with the dissolution of the Issuer.